Report ID :10085610 |
Published Date : 21 Mar 2025 |
Report Format : |
Delivery Timeline :48-72 Business Hours
Global Stem Cell Manufacturing Market Highlights Over 2022 - 2031
The global stem cell manufacturing market is estimated to grow at a CAGR of ~9% over the forecast period, i.e., 2022 – 2031. Moreover, the market registered a revenue of approximately USD 10.0 billion in 2021. The growth of the market can be attributed to the growing awareness for biologics and an increase in research to find out the best drug for the treatment of diseases. In addition, there has been a surge in neurological disorders across the globe for the treatment of which focus has been made on cells and tissues. Furthermore, according to the World Health Organization, hundreds of millions of people across the globe are affected by neurological disorders. Moreover, more than 6 million people die each year owing to strokes. Therefore, researchers are experimenting with stem cells to discover personalized medicines which are expected to increase the growth of the global stem cell manufacturing market.
GET A SAMPLE COPY OF THIS REPORT
The global stem cell manufacturing market is segmented by end-users into hospitals & surgical centers, pharmaceutical & biotechnology companies, research & academic institute, and others. Out of these, the pharmaceutical & biotechnology companies segment is expected to hold the largest share over the forecast period in the global stem cell manufacturing market owing to their growing focus on strategies for expanding their research in stem cells in order to stay ahead of other competitors.
Global Stem Cell Manufacturing Market Regional Synopsis
Regionally, the global stem cell manufacturing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. On the strength of the high prevalence of chronic diseases, advanced healthcare infrastructure, and an increase in research activities, the market in the North America region is anticipated to hold the largest over the forecast period. The market in the Asia Pacific region is estimated to witness modest growth over the forecast period on the back of an increase in the adoption of advanced technology and a surge in healthcare expenditure. Moreover, as per the World Bank, China’s health expenditure has increased from 4.51 percent of the GDP in 2000 to 5.35 percent of the GDP in 2019.
Market Segmentation
Our in-depth analysis of the global stem cell manufacturing market includes the following segments:
By End-Users
-
Hospitals & Surgical Centers
-
Pharmaceutical & Biotechnology Companies
-
Research & Academic Institute
-
Others
By Product
-
Consumables
-
Stem Cell Lines
-
Instruments
By Application
-
Research Application
-
Cell & Tissue Banking
-
Clinical Application
Growth Drivers and Challenges Impacting the Growth of the Global Stem Cell Manufacturing Market
Growth Drivers
-
Growing awareness of biologics
-
Surge in the prevalence of neurological disorders
Challenges
-
Lack of professionals for the use of stem cell
-
High cost of stem cell manufacturing
Key Companies Dominating the Global Stem Cell Manufacturing Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global stem cell manufacturing market that are included in our report are Merck KGaA, Vericel Corporation, VistaGen Therapeutics, Inc., Catalent, Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., Bristol Myers Squibb Company, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, and others.
Latest Developments in the Global Stem Cell Manufacturing Market:
-
19 April 2022: Applied Cells Inc. and STEMCELL Technologies Canada Inc. announced a partnership to develop a new high-performance cell separation solution that combines Applied Cells' MARS platform and STEMCELL's EasySep immunomagnetic cell separation kits.
-
27 May 2020: VistaGen Therapeutics, Inc., announced its agreement with Nuformix to develop new crystalline forms of AV-101 for the treatment of multiple CNS conditions.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Frequently Asked Question
The market is segmented by end-users, product, application, and by region.
The pharmaceutical & biotechnology companies segment is anticipated to hold largest market size in value over the forecast period and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
